학술논문

Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: The non-randomised, open-label, phase IIIb/IV CheckMate 920 trial
Document Type
Article
Source
In: BMJ Open. (BMJ Open, 14 September 2022, 12(9))
Subject
Language
English
ISSN
20446055